We recently compiled a list of the 10 Most Promising Dividend Stocks According to Hedge Funds. In this article, we are going ...

We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...

The Alzheimer’s Association advised against diagnosing the disease on biomarkers alone, but other experts said the genie ...

a pharmaceutical intelligence firm. Ozempic, Novo Nordisk’s semaglutide-based diabetes treatment, is expected to reap over $22 billion in sales. Eli Lilly and Company’s competing weight-loss ...

Ralph Lauren raised its annual revenue forecast on Thursday, betting on more younger shoppers picking up its spring ...

Pfizer reported $63.6 billion in revenue for the full year, up 7% compared to 2023. The full-year revenue beat Wall Street ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ... sparked a direct response by the pharma company to Twitter, requesting that ...

The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed, Logos ...